{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"FDA-approved test expands options for Alzheimer's disease: Joshua Bornhorst, Ph.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/6cffa20f\"></iframe>","width":"100%","height":180,"duration":763,"description":"Joshua Bornhorst, Ph.D., explains the differences between the new, FDA-approved Alzheimer's disease (AD) test and Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to give physicians flexibility and options for optimal patient care.","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}